October 19-27, 2024
43 participants, 24 women, 19 men from 11 countries
39 faculty from 12 countries
Faculty
D. Andes, University of Wisconsin, USA, T. Bachmann, Edinburgh Med. School, UK, S. Brisse, Institut Pasteur, France, E. Brown, McMaster University, Canada, M. Brown, Flinders University, Australia, R. Canton, Hospital Ramon y Cajal, Spain, J. Cervesi, Aurobac, France, R. Cirz, Revagenix, USA, J.-F. Collet, Université de Louvain, Belgium, P. Courvalin, Institut Pasteur, France, J.-D. Docquier, University of Siena, Italy, R. Ebright, Rutgers University, USA, M. Fisher, St Georges University, UK, M. Gilmore, Harvard Medical School, USA, Y. Grad, Harvard Medical School, USA, L. Hall-Stoodley, Ohio State University, USA, S. Helaine, Harvard Medical School, USA, D. Hughes, Uppsala University, Sweden, F. Lebreton, Army Institute of Resarch, USA, K. Lewis, Northeastern University, USA, S. Lory, Harvard Medical School, USA, A. Mankin, University of Illinois, USA, H. Moser, HEM consulting, USA, R. Müller, Helmoltz-Zentrum, Germany, A. Myers, Harvard University, USA, S. Nambiar, Johnson & Johnson, USA, R. Patel, Mayo Clinic, USA, M. Pinho, Universidad Nova de Lisboa, Portugal, S. Projan, Beat the Reaper, USA, E. Rocha, Institut Pasteur, France, H.-G. Sahl, University of Bonn, Germany, W. Shafer, Emory University, USA, J. Stokes, McMaster University, Canada, I. Stzepourginski, Eligo-bioscience, France, M.-W. Tan, Genentech/Roche, USA, U. Theuretzbacher, CEFAIA, Austria, P. Turner, Yale University, USA, N. Vàzquez-Laslop, University of Illinois, USA, G. Wright, McMaster University, Canada
